PF-05230907

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePF-05230907
Drug Alias NamePF-05230907PF-5230907PF-907
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionProthrombin stimulants
TargetsProthrombin
Therapy Area/IndicationsCerebral Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsCerebral Hemorrhage

Other Information

ATC CodeN/A
Related LinksN/A